Search research articles
Contact Us
Filters
Showing results (101-110 of 114) with videos related to
Page
of 12
Sort By:
Pharmacopsychiatry
|
September 3, 2008
Standardized remission criteria in schizophrenia: descriptive validity and comparability with previously used outcome measures
M Jäger, T Messer, G Laux, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
December 27, 2014
What are depressive symptoms in acutely ill patients with schizophrenia spectrum disorder?
R Schennach, M Riedel, M Obermeier, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
May 1, 2012
Insight in schizophrenia-course and predictors during the acute treatment phase of patients suffering from a schizophrenia spectrum disorder
R Schennach, S Meyer, F Seemüller, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
May 4, 2010
Response and remission of subjective well-being in patients suffering from schizophrenia spectrum disorders
R Schennach-Wolff, F Seemüller, M Obermeier, et al.
The Journal of Nutrition, Health & Aging
|
June 5, 2012
A combination of galantamine and memantine modifies cognitive function in subjects with amnestic MCI
O Peters, D Lorenz, A Fesche, et al.
Acta Psychiatrica Scandinavica
|
November 3, 2009
Outcome of suicidal patients with schizophrenia: results from a naturalistic study
R Schennach-Wolff, M Jäger, F Seemüller, et al.
Acta Psychiatrica Scandinavica
|
October 30, 2010
Evaluating depressive symptoms and their impact on outcome in schizophrenia applying the Calgary Depression Scale
R Schennach-Wolff, M Obermeier, F Seemüller, et al.
Pharmacopsychiatry
|
October 8, 2010
A critical analysis and discussion of the appropriateness of the schizophrenia consensus remission criteria in clinical pharmaceutical trials
R Schennach-Wolff, H-J Möller, M Jäger, et al.
Psychological Medicine
|
January 8, 2008
Vagus nerve stimulation for depression: efficacy and safety in a European study
T E Schlaepfer, C Frick, A Zobel, et al.
The Journal of Nutrition, Health & Aging
|
March 6, 2009
Evolution of Abeta42 and Abeta40 levels and Abeta42/Abeta40 ratio in plasma during progression of Alzheimer's disease: a multicenter assessment
K Blennow, G De Meyer, O Hansson, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 114) with videos related to
Sort By:
Page
of 12
Pharmacopsychiatry
|
September 3, 2008
Standardized remission criteria in schizophrenia: descriptive validity and comparability with previously used outcome measures
M Jäger, T Messer, G Laux, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
December 27, 2014
What are depressive symptoms in acutely ill patients with schizophrenia spectrum disorder?
R Schennach, M Riedel, M Obermeier, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
May 1, 2012
Insight in schizophrenia-course and predictors during the acute treatment phase of patients suffering from a schizophrenia spectrum disorder
R Schennach, S Meyer, F Seemüller, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
May 4, 2010
Response and remission of subjective well-being in patients suffering from schizophrenia spectrum disorders
R Schennach-Wolff, F Seemüller, M Obermeier, et al.
The Journal of Nutrition, Health & Aging
|
June 5, 2012
A combination of galantamine and memantine modifies cognitive function in subjects with amnestic MCI
O Peters, D Lorenz, A Fesche, et al.
Acta Psychiatrica Scandinavica
|
November 3, 2009
Outcome of suicidal patients with schizophrenia: results from a naturalistic study
R Schennach-Wolff, M Jäger, F Seemüller, et al.
Acta Psychiatrica Scandinavica
|
October 30, 2010
Evaluating depressive symptoms and their impact on outcome in schizophrenia applying the Calgary Depression Scale
R Schennach-Wolff, M Obermeier, F Seemüller, et al.
Pharmacopsychiatry
|
October 8, 2010
A critical analysis and discussion of the appropriateness of the schizophrenia consensus remission criteria in clinical pharmaceutical trials
R Schennach-Wolff, H-J Möller, M Jäger, et al.
Psychological Medicine
|
January 8, 2008
Vagus nerve stimulation for depression: efficacy and safety in a European study
T E Schlaepfer, C Frick, A Zobel, et al.
The Journal of Nutrition, Health & Aging
|
March 6, 2009
Evolution of Abeta42 and Abeta40 levels and Abeta42/Abeta40 ratio in plasma during progression of Alzheimer's disease: a multicenter assessment
K Blennow, G De Meyer, O Hansson, et al.
Page
of 12